Orange Book product · Generic (ANDA)
ETOPOSIDE
ETOPOSIDE
At a glance
Sep 19, 2001
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 19, 2001
25 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
ETOPOSIDE
Strength
50MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 075635
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of ETOPOSIDE
- 2026AVOPEFBrand (NDA)
NDA 220200 · AVYXA HOLDINGS
- 1986VEPESIDBrand (NDA)
NDA 019557 · ONESOURCE SPECIALTY
- 1983VEPESIDBrand (NDA)
NDA 018768 · CORDEN PHARMA
- 2017ETOPOSIDEGeneric (ANDA)
ANDA 203507 · NATCO PHARMA USA
- 2017ETOPOSIDEGeneric (ANDA)
ANDA 204927 · NATCO PHARMA USA
- 1998ETOPOSIDEGeneric (ANDA)
ANDA 074983 · FRESENIUS KABI USA
- 1998ETOPOSIDEGeneric (ANDA)
ANDA 074968 · WATSON LABS INC
- 1997ETOPOSIDEGeneric (ANDA)
ANDA 074813 · PIERRE FABRE
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074228 · WATSON LABS
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074529 · MEITHEAL
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074513 · ACCORD HLTHCARE
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074227 · PHARMACHEMIE BV
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
